Qube Research & Technologies (QRT)
COLL icon

Qube Research & Technologies (QRT)’s Collegium Pharmaceutical COLL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6M Sell
431,447
-190,488
-31% -$6.51M 0.01% 1033
2026
Q1 		$20.6M Buy
621,935
+353,693
+132% +$15M 0.02% 872
2025
Q4 		$12.4M Sell
268,242
-52,317
-16% -$2.19M 0.01% 1205
2025
Q3 		$11.2M Buy
320,559
+225,679
+238% +$7.84M 0.01% 1255
2025
Q2 		$2.81M Buy
94,880
+41,315
+77% +$1.18M ﹤0.01% 2035
2025
Q1 		$1.6M Sell
53,565
-164,248
-75% -$5.02M ﹤0.01% 2056
2024
Q4 		$6.24M Buy
217,813
+149,666
+220% +$4.95M 0.01% 1369
2024
Q3 		$2.63M Buy
68,147
+13,691
+25% +$488K ﹤0.01% 1665
2024
Q2 		$1.75M Buy
+54,456
New +$1.89M ﹤0.01% 1695
2024
Q1 		– Sell
-16,001
Closed -$493K – 4518
2023
Q4 		$493K Sell
16,001
-111,009
-87% -$2.78M ﹤0.01% 2293
2023
Q3 		$2.84M Buy
127,010
+111,394
+713% +$2.54M 0.01% 1196
2023
Q2 		$336K Sell
15,616
-19,348
-55% -$439K ﹤0.01% 1630
2023
Q1 		$839K Buy
+34,964
New +$927K ﹤0.01% 1362
2022
Q2 		– Sell
-19,699
Closed -$401K – 2583
2022
Q1 		$401K Sell
19,699
-62,177
-76% -$1.17M ﹤0.01% 1638
2021
Q4 		$1.53M Buy
81,876
+55,581
+211% +$1.08M 0.01% 956
2021
Q3 		$519K Buy
26,295
+8,280
+46% +$179K 0.01% 1198
2021
Q2 		$426K Sell
18,015
-1,844
-9% -$42.6K ﹤0.01% 1363
2021
Q1 		$471K Sell
19,859
-5,096
-20% -$121K 0.01% 1217
2020
Q4 		$500K Buy
+24,955
New +$487K 0.01% 1111
2020
Q1 		– Sell
-19,708
Closed -$406K – 1205
2019
Q4 		$406K Buy
+19,708
New +$329K 0.01% 1059

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s COLL Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Collegium Pharmaceutical (COLL) stake by 31% in Q2 2026, selling an estimated $6.51M and leaving 431,447 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #1033.

Qube Research & Technologies (QRT) first reported a position in COLL in Q4 2019 and has held it in 20 quarters since. The position peaked at $20.6M in Q1 2026. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Qube Research & Technologies (QRT) held 431,447 shares of Collegium Pharmaceutical worth $15.6M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 190,488 Collegium Pharmaceutical shares in Q2 2026, an estimated $6.51M.
  • Collegium Pharmaceutical made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1033 holding.
  • Qube Research & Technologies (QRT) first reported a position in Collegium Pharmaceutical in Q4 2019 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s Collegium Pharmaceutical position peaked at $20.6M in Q1 2026.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.